Metacrine (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 05, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $36,000,000
Company Info
- Founding Year
- 2015
- Founders
- Neil McDonnell
- Company Description
- Metacrine is a privately-held biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies.
- Market
- Metabolic Diseases
- Location
- San Diego, CA, USA
- Coinvestors
- ARCH Venture Partners, EcoR1 Capital, Polaris Partners